No abstract available
MeSH terms
-
Adenocarcinoma* / diagnosis
-
Adenocarcinoma* / genetics
-
Adenocarcinoma* / metabolism
-
Adenocarcinoma* / therapy
-
Antineoplastic Agents / therapeutic use
-
Chemotherapy, Adjuvant
-
Humans
-
Mutation
-
Neoplasm Metastasis
-
Neoplasm Staging
-
Pancreatic Neoplasms* / diagnosis
-
Pancreatic Neoplasms* / genetics
-
Pancreatic Neoplasms* / metabolism
-
Pancreatic Neoplasms* / therapy
-
Proto-Oncogene Proteins / genetics
-
Proto-Oncogene Proteins p21(ras)
-
Risk Factors
-
ras Proteins / genetics
Substances
-
Antineoplastic Agents
-
KRAS protein, human
-
Proto-Oncogene Proteins
-
Proto-Oncogene Proteins p21(ras)
-
ras Proteins